Glaxosmithkline traded at $30.11 this Friday October 7th, increasing $0.11 or 0.37 percent since the previous trading session. Looking back, over the last four weeks, Glaxosmithkline gained 4.44 percent. Over the last 12 months, its price fell by 22.22 percent. Looking ahead, we forecast Glaxosmithkline to be priced at 28.61 by the end of this quarter and at 26.29 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
30.11
Daily Change
0.37%
Yearly
-22.22%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,798.00 -35.00 -0.91% 18.72%
AbbVie 138.76 -1.53 -1.09% 24.81%
Aurora Cannabis Inc 1.58 -0.23 -12.71% -82.42%
Amgen 229.03 -1.91 -0.83% 9.61%
AstraZeneca 10,026.00 188.00 1.91% 12.79%
Bristol-Myers Squibb 69.70 -0.54 -0.77% 21.73%
Corcept Therapeutics 26.48 -0.36 -1.34% 30.19%
Catalent 77.02 -1.69 -2.15% -40.91%
Endo International 0.10 -0.002 -1.73% -97.49%
Glaxosmithkline 30.11 0.11 0.37% -22.22%
Horizon Pharma 65.00 -2.89 -4.26% -42.86%
Jazz Pharmaceuticals 135.80 -3.29 -2.37% -0.13%
J&J 160.20 -1.71 -1.06% -0.45%
Lannett 0.47 -0.01 -2.24% -82.41%
Eli Lilly 327.93 -6.29 -1.89% 40.18%
Merck & Co 87.60 0.16 0.18% 8.64%
Novartis 75.54 0 0% -1.38%
Phibro Animal Health 12.86 -0.14 -1.08% -41.60%
Prestige Brands 49.75 -0.10 -0.20% -14.28%
Pacira 56.31 -1.14 -1.98% 17.39%
Pfizer 42.32 -0.77 -1.79% -0.31%
Powershares High Yield Orate Bond Portfolio 16.65 -0.16 -0.95% -14.22%
Perrigo 38.09 -0.49 -1.27% -17.07%
Drreddys Laboratories 52.40 -0.35 -0.66% -18.53%
Roche Holding 324.50 -1.05 -0.32% -10.01%
Sanofi 80.16 0.83 1.05% -4.91%
Supernus Pharmaceuticals 33.29 -0.78 -2.29% 26.24%
Teva Pharmaceutical Industries Ltd 3,122.00 176.00 5.97% -4.53%
United States Oil Fund 75.10 2.11 2.89% 35.39%
Bausch Health Companies Inc 9.35 -0.83 -8.15% -73.09%
Canopy Growth Corp 3.83 -1.33 -25.78% -76.73%
Zoetis 147.37 -5.22 -3.42% -25.53%


Glaxosmithkline
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.